Department of Anesthesiology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, Wuhan 430061, China.
Department of Cardiothoracic Surgery, University Medical Center Regensburg, Franz-Josef-Strauss-Allee 1193053, Regensburg, Germany.
Int Immunopharmacol. 2023 Jul;120:110393. doi: 10.1016/j.intimp.2023.110393. Epub 2023 Jun 6.
Ferroptosis is involved in ischemia and reperfusion injury (IRI) of transplanted kidney. Understanding the molecular mechanisms of ferroptosis is essential to elucidate the pathogenesis of IRI. 1307 differentially expressed genes (DEGs) were obtained by GSE90861 retrieved from the GEO database. 29 ferroptosis-related DEGs were obtained from the intersection with FerrDb database, which were subjected to enrichment analysis and cytoHubba plugin for selecting the top three (IL6, ATF3 and JUN) as hub genes. Next, ROC analysis of hub genes showed good diagnostic prospects in both GSE90861 and GSE126805. Given the close link between ferroptosis and immunity, immunological analysis of CIBERSORTx revealed that the proportions of 10 cell types out of 22 immune cells in the transplanted kidney significantly changed after reperfusion. To study the relationship between IRI and ferroptosis, 15 male C57BL/6j mice were randomly divided into three groups: control (C), ischemia and reperfusion (IR), and IR + Fer-1 (IF) groups. The IRI mouse model not only developed significant histological damage changes, but also exhibited mitochondrial damage, iron accumulation, increased MDA, and decreased GSH. The ferroptosis inhibitor, Fer-1, ameliorated renal IRI, as demonstrated by rise of GPX4 and decline of TFRC, PTGS2 and ACSL4. In addition, hub genes were further confirmed by significant increase in IRI mouse model the same as the GEO database. In brief, ferroptosis-related hub genes (IL-6, ATF3 and JUN) screened were closely relevant to immune response and might be diagnostic biomarkers and therapeutic targets for IRI during renal transplantation, which could prevent renal allograft dysfunction.
铁死亡参与移植肾的缺血再灌注损伤(IRI)。了解铁死亡的分子机制对于阐明 IRI 的发病机制至关重要。从 GEO 数据库中检索到的 GSE90861 获得了 1307 个差异表达基因(DEGs)。从 FerrDb 数据库的交集获得了 29 个铁死亡相关的 DEGs,并对其进行了富集分析和 cytoHubba 插件选择前三个(IL6、ATF3 和 JUN)作为枢纽基因。接下来,枢纽基因的 ROC 分析在 GSE90861 和 GSE126805 中均显示出良好的诊断前景。鉴于铁死亡与免疫之间的密切联系,CIBERSORTx 的免疫分析表明,在再灌注后,22 种免疫细胞中的 10 种细胞类型在移植肾中的比例发生了显著变化。为了研究 IRI 与铁死亡之间的关系,将 15 只雄性 C57BL/6j 小鼠随机分为三组:对照组(C)、缺血再灌注组(IR)和 IR+Fer-1 组(IF)。IRI 小鼠模型不仅发展出明显的组织学损伤变化,而且还表现出线粒体损伤、铁积累、MDA 增加和 GSH 减少。铁死亡抑制剂 Fer-1 通过升高 GPX4 和降低 TFRC、PTGS2 和 ACSL4,改善了肾 IRI。此外,在 IRI 小鼠模型中,枢纽基因进一步得到证实,与 GEO 数据库中的结果相同。总之,筛选出的与铁死亡相关的枢纽基因(IL-6、ATF3 和 JUN)与免疫反应密切相关,可能是肾移植期间 IRI 的诊断生物标志物和治疗靶点,可防止肾移植功能障碍。